HL SELECT UK GROWTH SHARES

HL Select UK Growth Shares - December Review

Monthly roundup

Important information - The value of this fund can still fall so you could get back less than you invested, especially over the short term. The information shown is not personal advice and the information about individual companies represents our view as managers of the fund. It is not a personal recommendation to invest in a particular company. If you are at all unsure of the suitability of an investment for your circumstances please contact us for personal advice. The HL Select Funds are managed by our sister company HL Fund Managers Ltd.

Steve Clayton - Fund Manager

8 January 2018

The stock market in December

The UK stock market enjoyed a strong performance in December 2017, delivering a total return of 4.8%. This was driven by strength in commodity producers, pharmaceuticals, tobacco producers and housing stocks, offset by weakness in utilities. Optimism in the strength of the global economy and perhaps a sense of relief that some sort of a Brexit divorce had been agreed.

The December rally topped off a year of positive returns for the market, with the All Share index rising by 12.9% with dividends reinvested. With returns from bonds and cash remaining at very low levels, investors have been prepared to turn a blind eye to risks ranging from political upheavals to nuclear tensions. With higher interest rates expected on both sides of the Atlantic before too long, we believe this preference for yield in the face of risk could be tested in 2018.

HL Select UK Growth Shares in December

With a portfolio heavily exposed to global consumer names like Unilever and Diageo, as well as tech-driven businesses like GB Group and no positions in mining and energy stocks, a month like December was always going to be a challenge for the fund. In the event, the fund managed a rise of 3.3% over the month, to leave it ahead of the FTSE All-Share by more than 6% since launch in Dec 2016.

Biggest positive contributors

	Total return (%)	Contribution to fund (%)
Sanne Group	11.1	0.49
Rightmove	11.6	0.40
Ascential	8.8	0.35
British American Tobacco	8	0.28
Dominos Pizza	6.2	0.25

Past performance is not a guide to the future. Source: Bloomberg 01/12/2017 - 31/12/2017.

The total return column represents the stock’s return over the month, whilst the contribution column reflects how much that added or subtracted from the fund’s value. Thus Sanne Group rose by 11.1% in December, which added almost a half of a percent to the value of a unit in the fund.

With a limited number of trading days in the month and few scheduled trading updates from companies in December, the market tends to be driven at least as much by sentiment as information in the run-up to year end.

The move in Sanne was welcome, but we cannot point to any new news that emerged in the month to drive it. But there had been some earlier weakness, which we attributed to a persistent seller in the market. Their apparent absence appears to have allowed the stock to claw back towards previous levels. We next expect news from Sanne towards the end of January when they issue a trading update.

Equally, Rightmove’s strength came without any obvious catalyst, other than strength in housebuilding stocks, which rallied on hopes that future interest rate increases would be limited in scope.

Ascential had enjoyed a reasonable run-up to Christmas and then spiked towards the New Year after announcing the acquisition of Clavis, a specialist marketing consultancy. Clavis specialise in advising manufacturers how to position their brands and products across online platforms. It looks a good fit with Ascential’s One Click Retail business, which has grown like Topsy since it was bought a year or so ago. The market is hungry for online exposure and Ascential is fitting the bill nicely as it continues to position its portfolio further towards the digital economy.

British American Tobacco benefited from a solid pre-close trading update, with FX tailwinds and good volume performances from key brands helping to offset a weaker pricing environment in some markets.

Domino’s Pizza continues to recover from the weakness seen back in the spring. Recent trading updates have been good and the company recently announced plans to acquire a further stake in its Icelandic offshoot. We approve of the latter move; Icelanders are phenomenal consumers of pizza. For some reason they seem to prefer tucking in to a piping hot pizza delivery over traditional “delicacies” such as rotten shark meat. This could be a long term trend.

Biggest negative contributors

Stock	Total return (%)	Contribution to fund (%)
Burford Capital	-6.5	-0.36
Medica Group	-5.7	-0.16
Just Eat	-2.2	-0.1

Past performance is not a guide to the future. Source: Bloomberg 01/12/2017 - 31/12/2017.

Burford Capital fell by 6.5% in December, which subtracted just over a third of a percent from the value of a unit in the fund.

In early December Burford announced a positive trading statement, albeit brief and revealed that the founders of GKC, acquired roughly a year ago, would be stepping down, but retaining a long term interest in the funds they established. That saw some profit taking, already partially reversed.

Medica is relatively illiquid and fell in modest trading volumes. At the start of the month the Health Secretary highlighted the shortage of qualified radiologists and radiographers and announced plans to increase hiring of endoscopists to aid cancer diagnoses. This seems to reinforce Medica’s argument of a structural undersupply of the highly qualified radiologists needed to interpret scan data.

Annual percentage growth
	Jan 12 - Dec 13	Jan 13 - Dec 14	Jan 14 - Dec 15	Jan 15 - Dec 16	Jan 16 - Dec 17
HL Select UK Growth Shares	N/A*	N/A*	N/A*	N/A*	19.2%
FTSE All-Share Index	20.8%	1.2%	1.0%	16.8%	13.1%
IA UK All Companies	26.2%	0.5%	4.8%	11.2%	14.0%

*Full year performance not available

Past performance is not a guide to the future. Source: Lipper IM to 30 November 2017

View portfolio breakdown

More about HL Select UK Growth Shares

Non-Independent Research Disclosure

The information on this website is not intended to be advice or a recommendation to buy, sell or hold any investment mentioned. No view is given as to the present or future value or price of any investment, and investors should form their own view in relation to any proposed investment.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.

The research material provided on our website is not an offer to buy or sell any of the stocks mentioned. Hargreaves Lansdown accepts no responsibility for any use made of these comments and for any consequences that may result. We cannot guarantee the accuracy or completeness of the information provided and consideration has not been given to the personal circumstances of any investor. Therefore any person acting on it does so entirely at their own risk and must assess the suitability of any investment for their own personal circumstances and individual investment objectives. It is not a personal recommendation.

Although we are not specifically constrained from dealing ahead of any research material we do not seek to take advantage of it before it is provided to our clients. We aim to establish and maintain and operate effective organisational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients (including restrictions on dealing for writers of equity commentary).

Hargreaves Lansdown Fund Managers Ltd (HLFM) manages funds that may hold investments which are the subject of commentary prepared and published by other parts of the Hargreaves Lansdown group. Accordingly, appropriate organisational and administrative controls (including physical and information barriers, known as “Chinese Walls”) are in place between different parts of our business, including our marketing and fund management functions, in order to manage these potential conflicts of interest. For more information please see our Conflicts of Interest policy. HLFM currently manages three funds which hold individual equity securities. Details of the significant shareholdings held by these funds can be found here for the HL Select UK Growth Shares fund, here for the HL Select UK Income Shares fund and here for the HL Select Global Growth Shares fund. Hargreaves Lansdown (Nominees) Limited holds individual securities as nominee on behalf of underlying clients of Hargreaves Lansdown, and does not exercise control over or hold the beneficial ownership of these securities.

We do not intend to provide recommendations to buy, sell or hold particular investments, nor do we provide price targets. Our opinions on particular investments (and the facts underlying them) are valid as at the date of publication, but can change at any time, and we may not update our views on any particular investment on a regular basis. Accordingly such opinions and facts may become outdated or obsolete after the date of publication.

Issued by Hargreaves Lansdown Asset Management Limited, which is authorised and regulated by the Financial Conduct Authority (FCA Register number 115248, see FCA register for registration details) and registered in England and Wales No 1896481. Registered office: 1 College Square South, Anchor Road, Bristol BS1 5HL.

for more information. Unless otherwise stated performance figures are from Bloomberg and estimates, including prospective yields, are a consensus of analyst forecasts from Bloomberg. They are not a reliable indicator of future performance. Yields are variable and not guaranteed.